https://www.selleckchem.com/pr....oducts/proteinase-k.
The results suggest that alum, CpG ODN, and HH2 complex as a novel immune adjuvant combined cancer vaccine could improve the immunity efficiency in a murine multiple myeloma model. The failure of chemotherapy in osteosarcoma results in drug resistance and acute side effects in the body. In this study, we have prepared a novel folate receptor-targeted doxorubicin (DOX) and edelfosine (EDL)-loaded lipid-polymer hybrid nanoparticle (DE-FPLN) to enhance the anticancer efficacy in osteosarcoma. The nanoparticles were thoroughly characte
Like
Comment
Share
